Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
T2 Biosystems ( (TTOO) ) just unveiled an announcement.
T2 Biosystems has announced the successful defense of a crucial patent for its innovative blood pathogen detection method in the EU, bolstering its intellectual property portfolio. Despite opposition from bioMerieux and others, the European Patent Office backed T2 Biosystems’ patent, reinforcing the company’s strong position in direct-from-whole blood pathogen detection. This win is expected to enhance T2 Biosystems’ market leadership and support the advancement of its technology and product offerings.
Find detailed analytics on TTOO stock on TipRanks’ Stock Analysis page.